Regen BioPharma

(OTC) RGBP

Current Price$0.00

Market Cap$51.20K

Since IPO (2014)-100%

5 Year-100%

1 Year-100%

1 Month-58%

Regen BioPharma Financials at a Glance

Market Cap

$51.20K

Revenue (TTM)

$236.56K

Net Income (TTM)

-$715.69K

EPS (TTM)

-$0.03

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.00

Volume

2,752,301

Open

$0.00

Price

$0.00

Volume

2,752,301

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

May 11, 2026

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.00

Volume

2,752,301

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.12

Estimated Earnings Date

May 11, 2026

RGBP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Regen BioPharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Raymond Koos, MD, PhD

Website

www.regenbiopharmainc.com

Headquarters

La Mesa, CA 91942, US

RGBP Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-367.41%

Net Income Margin

-302.54%

Return on Equity

11.91%

Return on Capital

N/A

Return on Assets

-275.06%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$51.20K

Shares Outstanding

511.96M

Volume

2.75M

Avg. Volume

18.28M

Financials (TTM)

Gross Profit

$236.56K

Operating Income

-$869.14K

EBITDA

-$1.29M

Operating Cash Flow

-$477.16K

Capital Expenditure

$5.00

Free Cash Flow

-$477.16K

Cash & ST Invst.

$271.00

Total Debt

$959.15K

Regen BioPharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$59.07K

+0.0%

Gross Profit

$59.07K

+0.0%

Gross Margin

100.00%

N/A

Market Cap

$51.20K

N/A

Market Cap/Employee

$51.20K

N/A

Employees

N/A

Net Income

$991.93K

+5225.2%

EBITDA

-$145.05K

-1029.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$271.00

-84.6%

Total Debt

$959.15K

-0.9%

Accounts Receivable

$259.72K

+73.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$959.15K

-0.9%

Return on Assets

-2.75%

N/A

Return on Invested Capital

16.22%

N/A

Free Cash Flow

-$63.23K

+37.5%

Operating Cash Flow

-$63.23K

+37.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NBIONascent Biotech, Inc.

NBIONascent Biotech, Inc.$0.00+0.00%

IPIXInnovation Pharmaceuticals Inc.

IPIXInnovation Pharmaceuticals Inc.$0.00+0.00%

CBDGTHC Farmaceuticals, Inc.

CBDGTHC Farmaceuticals, Inc.$0.01+0.00%

WSNAFWesana Health Holdings Inc.

WSNAFWesana Health Holdings Inc.$0.02+0.00%

RASPActavia Life Sciences, Inc.

RASPActavia Life Sciences, Inc.$0.00+0.00%

VIRXViracta Therapeutics, Inc.

VIRXViracta Therapeutics, Inc.$0.01+0.00%

RSPIRespireRx Pharmaceuticals Inc.

RSPIRespireRx Pharmaceuticals Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

NOKNokia

NOKNokia$12.07-0.07%

RIVNRivian Automotive

RIVNRivian Automotive$18.63+0.08%

Questions About RGBP

What is the current price of Regen BioPharma?

Regen BioPharma is trading at $0.00 per share.

What is the 52-week range for Regen BioPharma?

Over the past 52 weeks, Regen BioPharma has traded between $0.00 and $0.12.

How much debt does Regen BioPharma have?

As of the most recent reporting period, Regen BioPharma reported total debt of $959.15K.

How much cash does Regen BioPharma have on hand?

Regen BioPharma reported $271.00 in cash and cash equivalents in its most recent financial results.

What is Regen BioPharma’s dividend yield?

Regen BioPharma does not currently have a dividend yield.

Regen BioPharma

Regen BioPharma Financials at a Glance

RGBP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Regen BioPharma

RGBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Regen BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RGBP

What is the current price of Regen BioPharma?

What is the 52-week range for Regen BioPharma?

How much debt does Regen BioPharma have?

How much cash does Regen BioPharma have on hand?

What is Regen BioPharma’s dividend yield?

Premium Investing Services